Table 1. Association of GAPLINC expression with clinical pathological parameters of patients with CRC.
Parameters | N | GAPLINC expression | P value | |
---|---|---|---|---|
Low | High | |||
Age (year) | 0.881 | |||
≤60 | 39 | 21 | 18 | |
>60 | 141 | 74 | 67 | |
Sex | 0.644 | |||
Female | 88 | 48 | 40 | |
Male | 92 | 47 | 45 | |
Tumor size (cm) | <0.01** | |||
≤5 | 101 | 70 | 31 | |
>5 | 77 | 23 | 54 | |
T stage | <0.01** | |||
1 | 13 | 9 | 4 | |
2 | 96 | 57 | 39 | |
3 | 66 | 27 | 39 | |
4 | 3 | 1 | 2 | |
N stage | <0.01** | |||
N0 | 111 | 67 | 44 | |
N1 | 51 | 24 | 27 | |
N2 | 18 | 4 | 14 | |
Grade | 0.116 | |||
I | 32 | 18 | 14 | |
II | 139 | 76 | 63 | |
III | 9 | 1 | 8 | |
Death | <0.01** | |||
No | 85 | 57 | 28 | |
Yes | 89 | 33 | 56 |
Statistically significant (P < 0.05).